Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00767533 · ClinicalTrials.gov registry record
Immunobiology of Cancer
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 84
- Enrollment target
NCT00767533: Clinical Trial study, sponsored by Stanford University.
NCT00767533 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00767533 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 84 participants
- Enrollment target
Study Summary
To learn whether or not an Interferon defect in cell signaling, recently discovered in immune cells from melanoma patients as well as breast cancer patients, is common to all cancers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-10 |
Why NCT00767533 stopped before completion
NCT00767533 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 84 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00767533 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00767533 about?
NCT00767533 is a clinical study titled "Immunobiology of Cancer". To learn whether or not an Interferon defect in cell signaling, recently discovered in immune cells from melanoma patients as well as breast cancer patients, is common to all cancers.
What is the current status of trial NCT00767533?
This trial is currently terminated. The enrollment target is 84 participants. The study started on 2008-10. Estimated completion is 2011-10.
Who is sponsoring clinical trial NCT00767533?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia